等待開盤 06-04 09:30:00 美东时间
-0.860
-1.94%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Steven Madden (SHOO) stock jumps after beating Q1 estimates and raising its 2026 sales outlook. Revenue rose 18% to $653.1M. Read more.
05-07 03:04
Needham analyst Tom Nikic maintains Steven Madden (NASDAQ:SHOO) with a Buy and raises the price target from $42 to $45.
05-07 02:17
Steven Madden (NASDAQ:SHOO) reported first-quarter financial results on Wednesd...
05-06 21:25
华盛资讯5月6日讯,史蒂夫·马登公布2026财年Q1业绩,公司Q1营收6.53亿美元,同比增长18.0%,归母净利润0.72亿美元,同比增长77.7%。
05-06 19:46
Steven Madden (NASDAQ:SHOO) is looking for FY2026 Adj EPS of $2.00-$2.10 vs $2.11 analyst estimate. Raises FY2026 sales outlook from $2.748 billion-$2.799 billion to $2.787 billion-$2.838 billion vs $2.798 billion
05-06 19:22
Steven Madden (NASDAQ:SHOO) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.39 by 15.38 percent. This is a 25 percent decrease over earnings of $0.60 per share from the same
05-06 18:59
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
今日重点评级关注:HC Wainwright & Co.:维持Immunic"买入"评级,目标价从5美元升至22美元;花旗:维持ServiceNow"买入"评级,目标价从154美元升至158美元
05-01 10:49